- Tether, a cryptocurrency issuer, has invested in BlackRock Neurotech, a maker of brain chips. This investment appears to be based on the assessment that brain chips have significant growth potential.
- BlackRock Neurotech, stablished in 2008, is a global leader in human brain-computer interface (BCI) technology, renowned for its advanced brain-computer interfaces.
Tether’s investment will be utilised to commercialise BlackRock Neurotech’s medical solutions and enhance research and development efforts.
Tether’s target
Tether, the world’s largest stablecoin operator, has invested $200 million in BlackRock Neurotech, as reported by blockchain media outlet Cointelegraph on the 29. The investment was made through Tether Evo, Tether’s new business unit.
Tether’s investment is aimed at raising funds for the commercialization and launch of BlackRock Neurotech’s medical solutions. Additionally, the investment will be used to enhance BlackRock Neurotech’s research and development efforts.
Also read: Tether partners with Celo network to expand USDT distribution
About Blackrock Neurotech
The company is dedicated to assisting millions of people worldwide who suffer from paralysis, loss of function, and neurological disorders, thus affecting their ability to walk, see, hear, feel, or speak.
A patient utilized BlackRock NeuroTech’s technology to control a robotic arm in 2016, , enabling them to bump fists with former U.S. President Barack Obama.
Also read: What is the overall cryptocurrency market cap?
The company’s technology has also played a crucial role in interpreting brain signals following neuromuscular disease or injury, aiding individuals in regaining the ability to speak.
